A series of aminoacetylenicoxyphthalimide namely N-[4-(t-amino)-2-butynyloxy] phthalimides were synthesized from the reaction of N-hydroxyphthalimide with propargyl bromide in sodium ethoxide to generate N-(2-butynyloxy)phthalimide. The desired compounds were prepared through Mannich reaction of N-(2-butynyloxy)phthalimide with formaldehyde, appropriate amine in peroxide-free dioxin and cuprous chloride as catalyst. The N-[4-(t-amino)-2-butynyloxy] phthalimides were investigated for their rectal temperature, motor activity and palpebral pitosis effects in comparison with harmaline, all compounds showed similar activity to harmaline, however compound 4 was more potent than harmaline.
Graphical abstract

Introduction
Acetylenic compounds and in particular aminoacetylenic compounds are of importance in many types of pharmacological activity. These activities may be shown in 0xotremorine antagonists [1, 2, 3] , their effects on behavioral functional changes and central motor effects [4, 5] . Aminoacetylenic compound showed Monoaminooxidase inhibitory activity type B as seen with Rasagiline (Azilect®)in treatment of Parkinson's disease [6, 7] , Clorgyline a drug used in depression treatment through monoaminooxidase A inhibition [8, 9, 10] . Furthermore, acetylenic compounds block H3 receptor and play important role in treatment of Alzheimer and other neurodegenerative disorders as seen with Perceptin [11] . In looking at www.iosrphr.org the structural features of the above mentioned drugs and going through most recent publications [12, 13] and to be away from their classical approaches we felt it will be of great interest to synthesize a novel series of N-[4-(t-amino)-2-butynyloxy] phthalimides (Table 1 ) and investigate their pharmacological activity. These aminoacetylenic compounds showed similar activity to harmaline in regard rectal hypothermic effects, spontaneous motor activity after reserpine treatment and inhibition of palpebral pitosis induce by reserpine. N-[4-(2,6-dimethylpiperidino)-2-butynyloxy] phthalimides 4 was equal or more than harmaline in potency.
Drugs with aminoacetylenic moiety
Oxotremorine antagonist N H www.iosrphr.org
Materials and Methods
N O O O CH 2 C C CH 2 N 2. 1. Compounds synthesized 1 N O O O CH 2 C C CH 2 N 2 N O O O CH 2 C C CH 2 N 3 CH 3 N O O O CH 2 C C CH 2 N 4 CH 3 CH 3
.2. Chemistry:
Melting points were determined by using a calibrated Thomas-Hoover melting apparatus. IR spectra were recorded using a Perkin-Elmer 257 spectrophotometer, 1H and 13CNMR were acquired with the aid of Bruker -DpX300 MHZ spectrometer with DMSO-d6 as solvent and TMS as internal standard. Microanalysis were performed in the laboratories of Dr.BernHardt, Mulheim, West Germany. The analyses were indicated only by symbols of the elements analyzed; the results obtained had a maximum deviation of ± 0.4% from the theoretical value.
www.iosrphr.org 
6. N-[4-(2,6-dimethypiperidino)-2-butynyloxy] phthalimide. 4
The title compound was prepared following the same procedure described for compounds 1-4 . 1HNMR (DMSO-d6): δ, 1.14, (d, 3H, J=4.2Hz, ( 12,12` CH3) 1.5 (m, 6H,10CH2-10`CH2-11CH2), 1.80 (m, 2H, 9,9`CH2 ), 3. 
3. Pharmcology:
2. 3. 1. Animals Albino Wistar rats of either sex, weighing 200-350 g were used throughout the study. They were maintained on a 12 hrs light-dark cycle and fed a commercial chow, water was given ad libitum. Rectal temperature was measured with thermistor probe and recorded on temperature recorder type Z94-B (ellab*). The resting temperature was first recorded, and then the test compound dissolved in sterile saline was injected intravenously. Rectal temperature was recorded again 2.5 hours after injection of compounds 1-4 (2 mg/kg) and 15 minutes after injection of harmaline (0.1 mg/kg).the same scheme was used for reserpinized rats. Reserpine (Ciba. 2 mg/kg)was injected intravenously 2 hours after the compounds 1-4 and 15 minutes after harmaline. Another record of the temperature was taken 30 minutes after reserpine injection. Palpebral pitosis was recorded on rats before and 30 minutes after reserpine injection. Other records were taken after administration of harmaline, compounds 1-4 plus reserpine. Scoring was based on a scale from 0 to 4, were 0 corresponds to totally open eye and 4 to totally closed eye. Albino mice were used for measurement of motor activity. Spontaneous motor activity was measured by using open field test [14] . The number of squares traversed by each mouse during 5 minutes was recorded before and after reserpine injection. Other records were taken after administration of harmaline, compounds 1-4 plus reserpine. For palpebral pitosis and motor activity, reserpine was injected intravenously 2 hours after the injection of compounds 1-4 and 15 minutes after the harmaline injection. Records were then taken 30 minutes after reserpine. In reserpinized animals, the dose of harmaline used was 2 mg/kg.
Pharmacological results
The hypothermic effects for harmaline and compounds 1-4 on the body temperature of rats were shown in (Table 2 ). The mean change in body temperature for compounds 1-4 were -0.5 oC, -0.7oC, -0.75 oC, -0.84 oC respectively; and -0.82 oC for harmaline. The hypothermic effect of harmaline was significantly higher than compounds 1-3 and less than that of compound 4. The results of prevention of hyperthermia induced by reserpine administration were shown in (Table 3 ). The initial response in rats to reserpine injection is hyperthermia+1.08±0.02. Harmaline modify this response and induce hypothermia in rats www.iosrphr.org (Table 4) . The prevention of palpebral pitosis induced by reserpine administration in rats is illustrated in (Table 5 ). Reserpine induced a complete pitosis. Harmaline and compound 4 completely antagonized this pitosis, while compounds 1-3 partially antagonize the pitosis. Rectal temperature was measured after reserpine alone, and after harmaline, compounds 1-4 plus Reserpine. Data are reported as the difference between the initial rectal temperature and the temperature of 45 minutes after harmaline administration and 2.5 hours after compounds 1-4 administration. Reserpine was injected 30 minutes before the second temperature reading. Data are presented as the mean ± S.E.M. for six rats. Doses of reserpine, compounds 1-4 and harmaline were 2 mg/kg given intravenously.
www.iosrphr.org Table 4 : Spontaneous motor activity after reserpine treatment, followed by harmaline and compounds 1-4.
Treatment
Mean number of square traversed by the mice during 5 minutes.
Saline 110 ± 17
Reserpine 22* ± 7
Compound 1 97* ± 5
Compound 2 99* ± 12
Compound 3 100* ± 9
Compound 4 110* ± 11
Harmaline 110 ± 11 *P＞0.05 when compared with saline treated animals Spontaneous motor activity after reserpine alone or after harmaline, compounds 1-4 plus reserpine. Each value represents a mean value ± S.E.M. for 10 mice. Doses of reserpine, compounds 1-4 and harmaline were 2 mg/kg given intravenously. 
Discussion
The induction of hypothermia in rats may suggest that compounds 1-4 are MAO inhibitors. It is well known that MAO inhibitors such as clorgyline, harmaline, (-) deprenyl and pargyline can induce similar effects in rats in doses range from 0.1-1 mg/kg [15] . The hypothermic activity of MAO inhibitors is probably due to their ability in preventing the metabolism of amines such as dopamine, tyramine or tryptamine [15] . Dopamine produces hypothermia when injected into rat brain ( [16] . However, the above test is not sufficient to indicate that these compounds are MAO inhibitors. CNS depressant in general produces hypothermia [17] . The experiments with reserpinized animals give more clear evidence on the MAO inhibitory activity of these four compounds. In rats, the initial response to reserpine injection is hyperthermia followed within hours by hypothermia. Pretreating rats with MAO inhibitors (Clorgyline www.iosrphr.org and harmaline in dose of 2 mg/kg) modify the response to reserpine and the hypothermia is the initial response [15] . Harmaline and compounds 1-4 were significantly block the hyperthermia induced by reserpine is probably due to the presence of 2-phenylethylamine chromophor within β -carboline [15] . Since reserpine releases endogenous amines from their storage sites [18, 19] . Reserpine depresses the motor activity of animals. However, while MAO inhibitors (harmaline) and compounds 1-4 significantly antagonize this depression. The prevention of depression in motor activity is probably due to the released amines such as noradrenaline and 5HT [15, 20] . The results of palpebral pitosis is in agreement with the suggestion that compounds 1-4 have MAO inhibitor activity. Palpebral pitosis after reserpine is probably due to the depletion of noradrenaline from sympathetic neurons [21] . Sympathetic neurons contain primarily MAO -A enzymes and noradrenaline is a substrate for MAO -A enzymes [15] . All the data from reserpinized rats and mice clearly support the suggestion that compound 1-4 have MAO inhibition activity. However, compounds 1-3 are weaker than harmaline as MAO inhibitor, while compound 4 is equally active or more potent than harmaline in the entire previous tests that is related to MAO inhibitory activity. Harmaline which is used in this work as standard MAO -A inhibitors might be more useful as antidepressents than the non specific inhibitor drugs [15] . Prior treatment of rats with MAO -A inhibitor prevents the depression of motor activity, palpebral pitosis and initial hyperthermia induced by treatment with reserpine. MAO -B inhibitors were ineffective in these tests, this suggested that dopamine and the other common substrates as well as the specific substrate for MAO -B are not responsible for much of the pharmacology of reserpine [15] . So the results of this work showed clear blockage to the depression of motor activity, palpebral pitosis and initial hyperthermia induced by reserpine. This indicated that compounds 1-4 are probably inhibit MAO -A enzymes. The order of activity for compounds 1-4 indicate that increase in the hydrocarbon that lead to higher lipophilicity afforded greater activity as seen with compound 4.Work in progress to verify the selectivity of compounds 1-4 toward MAO -A inhibitory activity.
Conclusion
The synthesis of aminoacetylenicoxyphthalimide and their pharmacological data provide a new series of compounds with specific MAO -A inhibitory activity. Further investigation is undergoing to confirm their selectivity towards MAO -A enzyme.
